Behind the Breakthroughs: Rare Disease Q&A with Catalina Olano-Marín
In this Q&A, Catalina Olano-Marín discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.
Upcoming Webinar: Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for...
Respiratory Innovation Moves Closer to Disease Modification
In September 2026, Medpace respiratory experts attended the ERS Congress in Barcelona, Spain. As the world’s largest respiratory meeting, the...
GAMRIC 2026 Recap: Advancing the Fight Against Antimicrobial Resistance (AMR)
Explore insights from Medpace medical and operational experts on several key themes that emerged from GAMRIC 2026
Overcoming the Greatest Barriers in Rare Disease Patient Recruitment
Every missed patient in a rare disease clinical trial represents more than a recruitment challenge, it represents a missed opportunity...
Upcoming Webinar: Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight
The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and...
Four Key Considerations for Recruiting an Undiagnosed Population
For many patients, the journey to a clinical trial does not begin with a diagnosis, it begins with unanswered questions....
Upcoming Webinar: Advancing Patient and Caregiver-Centered Approaches in Neurodegenerative Clinical Trials
Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex...
What Trends are Shaping Rheumatology Clinical Development in 2026?
The rheumatology landscape continues to evolve as new therapies, technologies, and strategies transform drug development. Many of these advances in...
Retina Development: The Next Era of Precision Therapies Is Here
Retina development continues to be driven by converging scientific, demographic, and commercial forces. With a rapidly growing patient population, and strong investor interest, there is a push for more assets into…